Rouskas Konstantinos, Bocher Ozvan, Simistiras Alexandros, Emmanouil Christina, Mantas Panagiotis, Skoulakis Anargyros, Park Young-Chan, Dimopoulos Alexandros, Glentis Stavros, Kastenmüller Gabi, Zeggini Eleftheria, Dimas Antigone S
Institute for Bioinnovation, Biomedical Sciences Research Center 'Alexander Fleming', Fleming 34, 16672 Vari, Greece.
Institute of Applied Biosciences, Centre for Research & Technology Hellas, Thessaloniki, Greece.
NPJ Metab Health Dis. 2025;3(1):14. doi: 10.1038/s44324-025-00057-2. Epub 2025 Apr 9.
Dietary interventions constitute powerful approaches for disease prevention and treatment. However, the molecular mechanisms through which diet affects health remain underexplored in humans. Here, we compare plasma metabolomic and proteomic profiles between dietary states for a unique group of individuals who alternate between omnivory and restriction of animal products for religious reasons. We find that short-term restriction drives reductions in levels of lipid classes and of branched-chain amino acids, not detected in a control group of individuals, and results in metabolic profiles associated with decreased risk for all-cause mortality. We show that 23% of proteins whose levels are affected by dietary restriction are druggable targets and reveal that pro-longevity hormone FGF21 and seven additional proteins (FOLR2, SUMF2, HAVCR1, PLA2G1B, OXT, SPP1, HPGDS) display the greatest magnitude of change. Through Mendelian randomization we demonstrate potentially causal effects of FGF21 and HAVCR1 on risk for type 2 diabetes, of HPGDS on BMI, and of OXT on risk for lacunar stroke. Collectively, we find that restriction-associated reprogramming improves metabolic health and emphasise high-value targets for pharmacological intervention.
饮食干预是疾病预防和治疗的有力方法。然而,饮食影响健康的分子机制在人类中仍未得到充分探索。在这里,我们比较了一组因宗教原因在杂食和限制动物产品摄入两种饮食状态之间交替的独特个体的血浆代谢组学和蛋白质组学特征。我们发现,短期限制会导致脂质类别和支链氨基酸水平降低,而在对照组个体中未检测到这种情况,并且会导致与全因死亡率风险降低相关的代谢特征。我们表明,受饮食限制影响的蛋白质中有23%是可成药靶点,并揭示长寿激素FGF21和另外七种蛋白质(FOLR2、SUMF2、HAVCR1、PLA2G1B、OXT、SPP1、HPGDS)变化幅度最大。通过孟德尔随机化,我们证明了FGF21和HAVCR1对2型糖尿病风险、HPGDS对体重指数以及OXT对腔隙性中风风险可能存在因果效应。总体而言,我们发现与限制相关的重新编程可改善代谢健康,并强调了药物干预的高价值靶点。